The restatement and material weakness disclosure are significant negative signals that will likely erode investor confidence and trigger shareholder litigation. Monitor for the filing of the 10-Q/A, any auditor commentary, and potential SEC inquiries. The board resignations, while officially not due to disagreements, add governance uncertainty. Traders should expect elevated volatility and potential downside pressure.
Price Chart
Executive Summary
AeroVironment filed an 8-K announcing a restatement of its Q3 FY2026 financials due to a goodwill impairment calculation error in the Space reporting unit, understating net loss by $87.3M and loss per share by $1.75-$1.79. The company also disclosed a material weakness in internal controls over financial reporting and the resignation of two board directors designated by Arlington Capital Partners, though the resignations are stated as not due to any disagreement with management.
Key Facts
- Restatement of unaudited financials for three and nine months ended January 31, 2026 due to goodwill impairment calculation error in Space reporting unit.
- Net loss understated by $87,272,000 for both the three and nine months ended January 31, 2026.
- Basic and diluted net loss per share understated by $1.75 (Q3) and $1.79 (nine months).
- Loss from operations understated by $89,402,000 for both periods.
- Total assets overstated by $89,402,000; total liabilities overstated by $2,130,000; total equity overstated by $87,272,000 as of January 31, 2026.
- Material weakness identified in internal control over financial reporting related to goodwill impairment analysis; disclosure controls deemed ineffective as of January 31, 2026.
- Error was non-cash and had no impact on previously reported revenues, cash from operations, or non-GAAP Adjusted EBITDA and non-GAAP diluted EPS.
- Two board directors (David Wodlinger and Henry Albers), designees of Arlington Capital Partners, resigned effective June 17, 2026, citing no disagreement with management.
- Arlington Capital Partners retains the right to designate two successor directors but has not yet done so.
Financial Impact
Net loss restated from $156.6M to $243.9M for Q3 FY2026 (increase of $87.3M); loss per share from $3.15 to $4.90. For nine months, net loss restated from $241.0M to $328.3M; loss per share from $4.94 to $6.73.
Risk Factors
- Shareholder lawsuits are highly probable following the restatement and material weakness disclosure.
- Potential SEC investigation or enforcement action related to the internal control failure.
- Further governance instability if Arlington Capital Partners does not promptly designate successor directors.
- Risk of additional goodwill impairments or accounting issues in other reporting units.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001104659-26-076140 |
| Document: 0001104659-26-076140-index-headers.html | 0001104659-26-076140 |
| Document: 0001104659-26-076140-index.html | 0001104659-26-076140 |
| Document: 0001104659-26-076140.txt | 0001104659-26-076140 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Aug 22, 2026 5w ago | Institutional Cluster | $148.20 $159.95 | ▲ +7.93% | ▲ +7.91% | $140.82 (−4.98%) |
Aug 7, 2026 8w ago | 8-K | $186.73 $144.65 | ▼ −22.54% | ▼ −22.14% | $140.82 (−24.59%) |
Jul 29, 2026 9w ago | 8-K | $142.12 $146.88 | ▲ +3.35% | ▼ −1.67% | $140.82 (−0.91%) |
Jun 29, 2026 13w ago | 8-K | $165.07 $154.24 | ▼ −6.56% | ▼ −5.53% | $140.82 (−14.69%) |
Jun 22, 2026 14w ago | 10-Q/A | $151.33 $142.20 | ▲ +6.03% | ▲ +5.89% | $140.82 (+6.95%) |
Jun 22, 2026 14w ago | 8-K | $151.33 $142.20 | ▲ +6.03% | ▲ +5.89% | $140.82 (+6.95%) |
Jun 11, 2026 16w ago | Institutional Cluster | $183.69 $148.40 | ▼ −19.21% | ▼ −21.10% | $140.82 (−23.34%) |
Apr 15, 2026 24w ago | 144 | $201.99 $160.99 | ▼ −20.30% | ▼ −26.11% | $140.82 (−30.28%) |
Apr 13, 2026 24w ago | 8-K | $194.39 $166.45 | ▼ −14.37% | ▼ −22.10% | $140.82 (−27.56%) |
Apr 9, 2026 25w ago | 8-K | $177.70 $174.37 | ▼ −1.87% | ▼ −9.44% | $140.82 (−20.75%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access